| Characteristic . | Univariate . | Multivariate . | ||||
|---|---|---|---|---|---|---|
| . | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
| AF vs. SR | 1.70 | 1.44–2.01 | <0.001 | 1.40 | 1.16–1.69 | <0.001 |
| Female vs. male | 0.83 | 0.70–0.99 | 0.035 | 0.97 | 0.79–1.18 | 0.8 |
| Age at procedure | 1.01 | 1.00–1.02 | 0.089 | 1.01 | 1.00–1.02 | 0.069 |
| Calcium score (by 100 AU) | 1.01 | 1.00–1.01 | 0.015 | 1.01 | 1.00–1.01 | 0.11 |
| Hypertension | 1.16 | 0.89–1.50 | 0.3 | |||
| Diabetes | 1.16 | 0.98–1.37 | 0.10 | 1.21 | 1.01–1.46 | 0.039 |
| Dialysis | 2.19 | 1.50–3.21 | <0.001 | 2.52 | 1.69–3.74 | <0.001 |
| LV stroke volume index | 0.98 | 0.97–0.99 | <0.001 | 1.00 | 0.99–1.01 | 0.4 |
| EF (%) | 0.98 | 0.98–0.99 | <0.001 | 0.99 | 0.99–1.00 | 0.076 |
| AV mean gradient | 0.99 | 0.98–1.0 | <0.001 | 0.99 | 0.98–1.00 | 0.029 |
| AV systolic area by TVI | 1.42 | 0.57–3.53 | 0.5 | |||
| CAD | 1.05 | 0.87–1.27 | 0.6 | |||
| Moderate/severe TR | 2.14 | 1.61–2.84 | <0.001 | 1.53 | 1.11–2.10 | 0.012 |
| Moderate/severe MR | 1.71 | 1.20–2.45 | 0.006 | 1.18 | 0.80–1.75 | 0.4 |
| RVSP | 1.02 | 1.01–1.02 | <0.001 | 1.01 | 1.00–1.02 | 0.014 |
| LA volume | 1.01 | 1.01–1.02 | <0.001 | 1.00 | 1.00–1.01 | 0.4 |
| Characteristic . | Univariate . | Multivariate . | ||||
|---|---|---|---|---|---|---|
| . | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
| AF vs. SR | 1.70 | 1.44–2.01 | <0.001 | 1.40 | 1.16–1.69 | <0.001 |
| Female vs. male | 0.83 | 0.70–0.99 | 0.035 | 0.97 | 0.79–1.18 | 0.8 |
| Age at procedure | 1.01 | 1.00–1.02 | 0.089 | 1.01 | 1.00–1.02 | 0.069 |
| Calcium score (by 100 AU) | 1.01 | 1.00–1.01 | 0.015 | 1.01 | 1.00–1.01 | 0.11 |
| Hypertension | 1.16 | 0.89–1.50 | 0.3 | |||
| Diabetes | 1.16 | 0.98–1.37 | 0.10 | 1.21 | 1.01–1.46 | 0.039 |
| Dialysis | 2.19 | 1.50–3.21 | <0.001 | 2.52 | 1.69–3.74 | <0.001 |
| LV stroke volume index | 0.98 | 0.97–0.99 | <0.001 | 1.00 | 0.99–1.01 | 0.4 |
| EF (%) | 0.98 | 0.98–0.99 | <0.001 | 0.99 | 0.99–1.00 | 0.076 |
| AV mean gradient | 0.99 | 0.98–1.0 | <0.001 | 0.99 | 0.98–1.00 | 0.029 |
| AV systolic area by TVI | 1.42 | 0.57–3.53 | 0.5 | |||
| CAD | 1.05 | 0.87–1.27 | 0.6 | |||
| Moderate/severe TR | 2.14 | 1.61–2.84 | <0.001 | 1.53 | 1.11–2.10 | 0.012 |
| Moderate/severe MR | 1.71 | 1.20–2.45 | 0.006 | 1.18 | 0.80–1.75 | 0.4 |
| RVSP | 1.02 | 1.01–1.02 | <0.001 | 1.01 | 1.00–1.02 | 0.014 |
| LA volume | 1.01 | 1.01–1.02 | <0.001 | 1.00 | 1.00–1.01 | 0.4 |
Bold values are statistically significant.
HR, hazard ratio; CI, confidence interval; AF, atrial fibrillation; SR, sinus rhythm; AU, arbitrary units; LV, left ventricle; EF, ejection fraction; AV, aortic valve; TVI, time velocity integral; CAD, coronary artery disease; TR, tricuspid regurgitation; MR, mitral regurgitation; RVSP, right ventricular systolic pressure; LA, left atrium.
| Characteristic . | Univariate . | Multivariate . | ||||
|---|---|---|---|---|---|---|
| . | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
| AF vs. SR | 1.70 | 1.44–2.01 | <0.001 | 1.40 | 1.16–1.69 | <0.001 |
| Female vs. male | 0.83 | 0.70–0.99 | 0.035 | 0.97 | 0.79–1.18 | 0.8 |
| Age at procedure | 1.01 | 1.00–1.02 | 0.089 | 1.01 | 1.00–1.02 | 0.069 |
| Calcium score (by 100 AU) | 1.01 | 1.00–1.01 | 0.015 | 1.01 | 1.00–1.01 | 0.11 |
| Hypertension | 1.16 | 0.89–1.50 | 0.3 | |||
| Diabetes | 1.16 | 0.98–1.37 | 0.10 | 1.21 | 1.01–1.46 | 0.039 |
| Dialysis | 2.19 | 1.50–3.21 | <0.001 | 2.52 | 1.69–3.74 | <0.001 |
| LV stroke volume index | 0.98 | 0.97–0.99 | <0.001 | 1.00 | 0.99–1.01 | 0.4 |
| EF (%) | 0.98 | 0.98–0.99 | <0.001 | 0.99 | 0.99–1.00 | 0.076 |
| AV mean gradient | 0.99 | 0.98–1.0 | <0.001 | 0.99 | 0.98–1.00 | 0.029 |
| AV systolic area by TVI | 1.42 | 0.57–3.53 | 0.5 | |||
| CAD | 1.05 | 0.87–1.27 | 0.6 | |||
| Moderate/severe TR | 2.14 | 1.61–2.84 | <0.001 | 1.53 | 1.11–2.10 | 0.012 |
| Moderate/severe MR | 1.71 | 1.20–2.45 | 0.006 | 1.18 | 0.80–1.75 | 0.4 |
| RVSP | 1.02 | 1.01–1.02 | <0.001 | 1.01 | 1.00–1.02 | 0.014 |
| LA volume | 1.01 | 1.01–1.02 | <0.001 | 1.00 | 1.00–1.01 | 0.4 |
| Characteristic . | Univariate . | Multivariate . | ||||
|---|---|---|---|---|---|---|
| . | HR . | 95% CI . | P-value . | HR . | 95% CI . | P-value . |
| AF vs. SR | 1.70 | 1.44–2.01 | <0.001 | 1.40 | 1.16–1.69 | <0.001 |
| Female vs. male | 0.83 | 0.70–0.99 | 0.035 | 0.97 | 0.79–1.18 | 0.8 |
| Age at procedure | 1.01 | 1.00–1.02 | 0.089 | 1.01 | 1.00–1.02 | 0.069 |
| Calcium score (by 100 AU) | 1.01 | 1.00–1.01 | 0.015 | 1.01 | 1.00–1.01 | 0.11 |
| Hypertension | 1.16 | 0.89–1.50 | 0.3 | |||
| Diabetes | 1.16 | 0.98–1.37 | 0.10 | 1.21 | 1.01–1.46 | 0.039 |
| Dialysis | 2.19 | 1.50–3.21 | <0.001 | 2.52 | 1.69–3.74 | <0.001 |
| LV stroke volume index | 0.98 | 0.97–0.99 | <0.001 | 1.00 | 0.99–1.01 | 0.4 |
| EF (%) | 0.98 | 0.98–0.99 | <0.001 | 0.99 | 0.99–1.00 | 0.076 |
| AV mean gradient | 0.99 | 0.98–1.0 | <0.001 | 0.99 | 0.98–1.00 | 0.029 |
| AV systolic area by TVI | 1.42 | 0.57–3.53 | 0.5 | |||
| CAD | 1.05 | 0.87–1.27 | 0.6 | |||
| Moderate/severe TR | 2.14 | 1.61–2.84 | <0.001 | 1.53 | 1.11–2.10 | 0.012 |
| Moderate/severe MR | 1.71 | 1.20–2.45 | 0.006 | 1.18 | 0.80–1.75 | 0.4 |
| RVSP | 1.02 | 1.01–1.02 | <0.001 | 1.01 | 1.00–1.02 | 0.014 |
| LA volume | 1.01 | 1.01–1.02 | <0.001 | 1.00 | 1.00–1.01 | 0.4 |
Bold values are statistically significant.
HR, hazard ratio; CI, confidence interval; AF, atrial fibrillation; SR, sinus rhythm; AU, arbitrary units; LV, left ventricle; EF, ejection fraction; AV, aortic valve; TVI, time velocity integral; CAD, coronary artery disease; TR, tricuspid regurgitation; MR, mitral regurgitation; RVSP, right ventricular systolic pressure; LA, left atrium.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
